• 2 Citations
  • 1 h-Index
20182018
If you made any changes in Pure these will be visible here soon.

Research Output 2018 2018

  • 2 Citations
  • 1 h-Index
  • 2 Article
2018

Outcomes of ALK positive lung cancer patients treated with crizotinib or second-generation ALK inhibitor: A monoinstitutional experience

De Carlo, E., Del Savio, M. C., Polesel, J., Da Ros, V., Berto, E., Santarossa, S., Chimienti, E., Fratino, L. & Bearz, A., Jan 1 2018, In : Oncotarget. 9, 20, p. 15340-15349 10 p.

Research output: Contribution to journalArticle

Lung Neoplasms
Non-Small Cell Lung Carcinoma
Survival
Retrospective Studies
anaplastic lymphoma kinase
2 Citations (Scopus)

Therapeutic decision based on molecular detection of resistance mechanism in an ALK-rearranged lung cancer patient: A case report

De Carlo, E., Schiappacassi, M., Urbani, M., Doliana, R., Baldassarre, G., Da Ros, V., Santarossa, S., Chimienti, E., Berto, E., Fratino, L. & Bearz, A., Jan 1 2018, In : OncoTargets and Therapy. 11, p. 8945-8950 6 p.

Research output: Contribution to journalArticle

Lung Neoplasms
Mutation
Protein-Tyrosine Kinases
Therapeutics
Biopsy